EWTX logo

Edgewise Therapeutics (EWTX) Cash and cash equivalents

annual cash & cash equivalents:

$41.67M-$44.43M(-51.61%)
December 31, 2024

Summary

  • As of today (July 6, 2025), EWTX annual cash & cash equivalents is $41.67 million, with the most recent change of -$44.43 million (-51.61%) on December 31, 2024.
  • During the last 3 years, EWTX annual cash & cash equivalents has risen by +$26.10 million (+167.67%).
  • EWTX annual cash & cash equivalents is now -60.29% below its all-time high of $104.92 million, reached on December 31, 2020.

Performance

EWTX Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

quarterly cash & cash equivalents:

$49.92M+$8.26M(+19.81%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX quarterly cash & cash equivalents is $49.92 million, with the most recent change of +$8.26 million (+19.81%) on March 31, 2025.
  • Over the past year, EWTX quarterly cash & cash equivalents has increased by +$19.66 million (+64.95%).
  • EWTX quarterly cash & cash equivalents is now -77.41% below its all-time high of $221.04 million, reached on March 31, 2021.

Performance

EWTX quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

EWTX Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-51.6%+65.0%
3 y3 years+167.7%+44.9%
5 y5 years+76.2%-

EWTX Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-51.6%+167.7%-54.5%+172.2%
5 y5-year-60.3%+167.7%-77.4%+372.2%
alltimeall time-60.3%+167.7%-77.4%+372.2%

EWTX Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$49.92M(+19.8%)
Dec 2024
$41.67M(-51.6%)
$41.67M(-7.0%)
Sep 2024
-
$44.81M(+3.0%)
Jun 2024
-
$43.48M(+43.7%)
Mar 2024
-
$30.26M(-64.8%)
Dec 2023
$86.10M(+291.5%)
$86.10M(+161.2%)
Sep 2023
-
$32.96M(+3.6%)
Jun 2023
-
$31.81M(-34.1%)
Mar 2023
-
$48.23M(+119.3%)
DateAnnualQuarterly
Dec 2022
$21.99M(+41.3%)
$21.99M(-80.0%)
Sep 2022
-
$109.75M(+498.4%)
Jun 2022
-
$18.34M(-46.8%)
Mar 2022
-
$34.45M(+121.3%)
Dec 2021
$15.57M(-85.2%)
$15.57M(+47.3%)
Sep 2021
-
$10.57M(-79.0%)
Jun 2021
-
$50.40M(-77.2%)
Mar 2021
-
$221.04M(+110.7%)
Dec 2020
$104.92M(+343.6%)
$104.92M
Dec 2019
$23.65M
-

FAQ

  • What is Edgewise Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Edgewise Therapeutics quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly cash & cash equivalents year-on-year change?

What is Edgewise Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of EWTX is $41.67M

What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual cash & cash equivalents is $104.92M

What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, EWTX annual cash & cash equivalents has changed by -$44.43M (-51.61%)

What is Edgewise Therapeutics quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of EWTX is $49.92M

What is the all time high quarterly cash & cash equivalents for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly cash & cash equivalents is $221.04M

What is Edgewise Therapeutics quarterly cash & cash equivalents year-on-year change?

Over the past year, EWTX quarterly cash & cash equivalents has changed by +$19.66M (+64.95%)
On this page